Ceva Santé Animale was created in 1999, after an initial LMBO (employee buyout). Since then, Ceva’s growth has continued to accelerate.
Ceva has two areas of expertise: pharmaceuticals and biology. The company has specialized teams working to meet the specific needs of the ruminant, poultry, swine and pet sectors.
Company sold in 2020.
Investor(s):
Alexandre Sagon, Rémi Chériaux
Alexandre Sagon, Rémi Chériaux
Participation: majoritaire
Activities:
Veterinary pharmaceuticals.
Leaders:
Marc Prikazsky
IXO intervention: 8 M€
Sales figures: 1061 M€ (2018)